Related Experiment Video
Updated: Jan 16, 2026

Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
Age-Specific Pharmacology of Neuromuscular Blocking Agents: A Comprehensive Review
Paweł Radkowski1,2,3, Kacper Kowalczyk4, Anna Łęczycka4
1Department of Anesthesiology and Intensive Care, Faculty of Medicine, Collegium Medicum University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Abstract:
Neuromuscular blocking agents (NMBAs) are essential in anesthesia, used primarily for intubation and synchronizing mechanical ventilation. They can be divided into depolarizing and non-depolarizing agents with an addition of reversal agents, which can be used to avoid residual muscle blockade. Their pharmacological properties vary among age groups due to physiological differences. In children, immature liver and kidney function, body composition, and immature neuromuscular junction influence drug properties. Elderly patients tend to have reduced organ function, more comorbidities, and greater vulnerability to stress. Ensuring anesthesia safety and preventing complications often requires adjusting doses and delivery regimens, which can be problematic, especially among inexperienced anesthesia personnel. To address this issue, we created this review to clarify dosage differences and their physiological bases. The article provides an overview of numerous clinical studies, including recent ones conducted on age-diverse patient populations, which, combined with an explanation of the pharmacological basis of NMBAs, is a valuable resource for anesthesiology with various levels of experience. The manuscript was based on 131 articles dating from 1987 to 2025, as well as the authors' knowledge and clinical experience.
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Neuromuscular Junction And Blockade
Drugs Acting on Autonomic Ganglia: Blockers

